Yahoo Canada Web Search

Search results

1. BIIB - Biogen Inc.

   Yahoo Finance

   • Range :
   • 1d
   • 5d
   • 6m
   • 1y
   • Max

   228.07+2.42 (+1.07%)

   at Mon, Jul 8, 2024, 4:00PM EDT - U.S. markets closed

   After Hours 229.00 +0.93 (+0.41%)

   Nasdaq Real Time Price

   • Open 226.47
   • High 229.41
   • Low 225.80
   • Prev. Close 225.65

   • 52 Wk. High 281.68
   • 52 Wk. Low 189.44
   • P/E 28.47
   • Mkt. Cap 33.21B

   • NasdaqGS
   • •Price in USD

2. www.biogen.comHome | Biogen

   www.biogen.com

   • Cached

   Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...

   • Responsibility

     For Biogen, that includes bolstering our commitment to...

   • Alzheimer's Disease

     Biogen’s commitment to health equity is rooted in efforts...

   • Amyotrophic Lateral Sclerosis

     Kate was busy planning her wedding when she was diagnosed...

   • Lupus

     Biogen’s decades of study at the crossroads of neurology and...

   • Multiple Sclerosis

     Multiple sclerosis (MS) is a complex, heterogeneous, chronic...

   • Spinal Muscular Atrophy

     SMA, an inherited disease that can have a devastating effect...

   • Investor Relations

     Founded in 1978, Biogen is a leading biotechnology company...

   • News Releases

     Biogen Announces Webcast of Annual Meeting of Stockholders....

3. en.wikipedia.org › wiki › BiogenBiogen - Wikipedia

   en.wikipedia.org › wiki › Biogen

   • Cached

   Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan ...

4. www.biogen.com › companyCompany | Biogen

   www.biogen.com › company

   • Cached

   Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease.

5. finance.yahoo.com › quote › BIIBBiogen Inc. (BIIB) - Yahoo Finance

   finance.yahoo.com › quote › BIIB

   • Cached

   Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.

6. www.cnbc.com › 2021/06/07 › fda-approves-biogensBiogen’s Alzheimer’s drug approved by FDA, first new therapy ...

   www.cnbc.com › 2021/06/07 › fda-approves-biogens

   • Cached

   Jun 7, 2021 · Biogen's aducanumab is the first new therapy for Alzheimer's in nearly two decades and the first to slow cognitive decline. The FDA granted approval with a condition that Biogen conduct another clinical trial, while the drug's price is $56,000 per year.

   • Author: Berkeley Lovelace Jr.

   • Video Duration: 2 min

7. www.biogen.com › science-and-innovationScience & Innovation | Biogen

   www.biogen.com › science-and-innovation

   • Cached

   Biogen has pioneered the development of multiple sclerosis treatments for more than 25 years. We continue to innovate to advance MS treatment and improve outcomes for patients. Our research is focused on potentially transformative therapies, including the potential repair of the damage caused by MS.

8. People also ask

   Who is Biogen?

   • Company Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases.

   Company | Biogen

   www.biogen.com/company.html

   See all results for this question

   Who is Biogen & why should you care?

   • Founded in 1978, Biogen has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Where science meets humanity

   Company | Biogen

   www.biogen.com/company.html

   See all results for this question

   Is Biogen a stock?

   • Biogen stock is a component of several stock indices such as the S&P 500, S&P 1500, and NASDAQ-100 and the company is listed on the NASDAQ stock exchange under the ticker symbol, BIIB. In May 2006, the company announced it would acquire cancer specialist, Conforma Therapeutics for $250 million.

   Biogen - Wikipedia

   en.wikipedia.org/wiki/Biogen

   See all results for this question

   Is Biogen a drug candidate?

   • Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases. Biogen is a biotech company that develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases.

   Biogen Inc. (BIIB) Stock Price, News, Quote & History - Yahoo Finance

   finance.yahoo.com/quote/BIIB/

   See all results for this question

9. www.marketwatch.com › investing › stockBIIB Stock Price | Biogen Inc. Stock Quote (U.S.: Nasdaq ...

   www.marketwatch.com › investing › stock

   6 days ago · Get the latest price, performance, and analysis of Biogen Inc. (BIIB), a biopharmaceutical company that develops therapies for neurological and neurodegenerative diseases. See its products, competitors, earnings, and more.